Ambrx pulls in $200m

California-based Ambrx Inc, a clinical-stage biopharmaceutical company, has raised $200 million in financing.

California-based Ambrx Inc, a clinical-stage biopharmaceutical company, has raised $200 million in financing. The backers included Fidelity Management & Research Company LLC, BlackRock, Cormorant Asset Management, HBM Healthcare Investments, Invus, Adage Capital Partners and Suvretta Capital Management. BofA Securities was the placement agent.

Source: Press Release